Fasting + Rapamycin (Sirolimus) Protocol · Tomorrow Today Longevity

The Fasting + Rapamycin Protocol represents a cutting-edge approach to longevity, combining the ancient practice of fasting with the modern pharmaceutical rapamycin (also known as sirolimus). This protocol is designed to enhance the body’s natural cellular repair processes and metabolic health by targeting a key driver of aging called the mTOR pathway. It is particularly relevant for individuals interested in advanced longevity strategies, metabolic health optimization, and reducing disease risk as they age. While still emerging in clinical research, this combined intervention is gaining attention for its potential to promote healthy aging beyond what fasting or rapamycin might achieve alone.

How It Works

At the heart of this protocol is the mechanistic target of rapamycin complex 1 (mTORC1), a protein complex that regulates cell growth, metabolism, and aging. Under normal conditions, mTORC1 is activated by signals such as insulin, amino acids, and growth factors, promoting cellular growth and nutrient use.

Fasting naturally suppresses mTORC1 activity by lowering circulating insulin and amino acid levels. This creates a metabolic state where the body shifts from growth mode to repair mode, triggering a process called autophagy. Autophagy is like the cell’s recycling system—damaged proteins and worn-out cellular components are broken down and removed, helping to maintain cellular health and function.

Rapamycin complements fasting by directly inhibiting mTORC1. It binds to a protein called FKBP12, which then blocks mTORC1’s activity more potently and persistently than fasting alone. This deeper inhibition amplifies autophagy and cellular renewal processes.

Together, fasting and rapamycin create a powerful synergy:

Enhanced autophagy: More efficient clearing of cellular “debris” supports tissue rejuvenation.
Metabolic reprogramming: Both reduce insulin and IGF-1 signaling, improve insulin sensitivity, and increase metabolic flexibility.
Inflammation reduction: Lowered metabolic stress can reduce chronic inflammation linked to aging and disease.

This combined approach mimics some effects of caloric restriction, a well-studied longevity intervention, but with potentially greater impact on key aging pathways.

What the Evidence Says

Research into the Fasting + Rapamycin Protocol is still evolving, largely in translational and early clinical studies (Tier 3 evidence). Animal studies have consistently shown that rapamycin extends lifespan and improves markers of metabolic health, and fasting has long been recognized for its benefits in promoting autophagy and metabolic regulation.

Emerging human research suggests:

Safety and tolerability: Low-dose rapamycin used intermittently under physician supervision appears safe for select healthy adults.
Metabolic benefits: Studies indicate improvements in insulin sensitivity and markers of inflammation when rapamycin is combined with fasting or caloric restriction.
Potential neuro- and cardio-protective effects: By promoting cellular repair and reducing metabolic stress, this protocol may support brain and cardiovascular health, though definitive human data are pending.

However, limitations remain:

Large-scale, long-term clinical trials in humans are lacking.
Optimal dosing schedules and fasting protocols require personalization and careful medical oversight.
Rapamycin’s immunosuppressive effects at higher doses warrant caution.

In summary, early evidence supports the promise of this combined approach, but more rigorous research is needed to fully understand its benefits and risks.

Clinical Context

In clinical and precision longevity settings, the Fasting + Rapamycin Protocol is emerging as a tailored intervention for adults aiming to extend healthspan and address metabolic concerns. Typical use involves:

Periodic fasting: This may include intermittent fasting (e.g., 16-24 hour fasts) or longer fasts spaced weeks apart.
Low-dose rapamycin: Administered intermittently, often weekly or biweekly, under close supervision by a qualified healthcare provider.
Monitoring: Regular blood tests to assess immune function, metabolic markers, and kidney/liver health are essential to ensure safety.
Integration: Often combined with other wellness strategies such as peptide therapies or stem cell treatments in specialized clinics.

Ideal candidates are generally middle-aged or older adults in good health without active infections or immune compromise. Those with metabolic syndrome, early type 2 diabetes (as an adjunct), or elevated cardiovascular risk may particularly benefit, though individualized assessment is crucial.

Because rapamycin is a prescription medication with immunomodulatory effects, this protocol must be managed by experienced physicians familiar with longevity medicine to optimize dosing and reduce potential side effects.

Key Takeaways

The Fasting + Rapamycin Protocol leverages combined suppression of the mTORC1 pathway to promote cellular repair, autophagy, and metabolic health.
This approach may support healthy aging and reduce risks associated with metabolic syndrome, neurodegeneration, and cardiovascular disease.
Early evidence suggests safety and efficacy in select populations, but physician supervision and regular monitoring are essential.
More research is needed to establish optimal protocols and long-term outcomes in humans.

Frequently Asked Questions

Is the Fasting + Rapamycin Protocol safe for everyone?
Safety depends on individual health status and requires supervision by a qualified healthcare provider. Rapamycin can affect immune function, so it’s not suitable for people with infections or certain medical conditions.

How often should rapamycin be taken with fasting?
Dosing schedules vary and should be personalized. Typical protocols use low doses weekly or biweekly alongside fasting periods, all under medical supervision.

Can I do this protocol on my own at home?
Because of rapamycin’s prescription status and potential side effects, this protocol should only be undertaken with guidance from a knowledgeable physician experienced in longevity medicine.